Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.

Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4+ T cells.
复制标题

DOI:
10.1371/journal.pone.0089266
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Yasutomo K
Yasutomo K
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Bhuyan ZA;Asanoma M;Iwata A;Ishifune C;Maekawa Y;Shimada M;Yasutomo K

文献摘要

参考文献

被引文献

相似文献

实验性自身免疫性葡萄膜视网膜炎(EAU)是用光感受器间视黄酸结合蛋白(IRBP)免疫小鼠而引起的一种器官特异性T细胞介导的疾病。自身侵袭性CD4+T细胞是EAU的主要致病细胞群。我们研究了T细胞中的Notch信号在EAU发病机制中的作用,因为Notch信号调节着CD4+T细胞功能的各个方面。Rbpj是Notch信号转导所必需的,T细胞中Rbpj缺乏抑制了EAU疾病的严重程度。T细胞特异性Rbpj缺陷小鼠EAU的改善与CD4+T细胞产生IL-22的低水平有关,尽管IRBP特异性CD4+T细胞的增殖和Th17分化没有受到影响。在EAU的晚期而不是早期阶段应用重组IL-22可提高T细胞特异性Rbpj缺陷小鼠的EAU临床评分。用γ分泌酶抑制剂(GSI)免疫IRBP的小鼠,即使在免疫后13天才给予GSI,也能抑制EAU的进展。我们的数据表明Rbpj/Notch介导的T细胞产生IL-22在EAU的晚期具有重要的病理作用,并提示Notch阻断可能是治疗EAU的一种有效的治疗方法。
Experimental autoimmune uveoretinitis (EAU) is an organ-specific T cell-mediated disease induced by immunizing mice with interphotoreceptor retinoid binding protein (IRBP). Autoaggressive CD4+ T cells are the major pathogenic population for EAU. We investigated the contribution of Notch signaling in T cells to EAU pathogenesis because Notch signaling regulates various aspects of CD4+ T cell functions. Rbpj is required for Notch signaling, and Rbpj deficiency in T cells inhibited EAU disease severity. The amelioration of EAU in T cell-specific Rbpj-deficient mice correlated with low levels of IL-22 production from CD4+ T cells, although IRBP-specific CD4+ T cell proliferation and Th17 differentiation were unaffected. Administration of recombinant IL-22 during the late phase, but not the early phase, of EAU increased EAU clinical scores in T cell-specific Rbpj-deficient mice. Notch inhibition in mice immunized with IRBP with a γ-secretase inhibitor (GSI) suppressed EAU progression, even when GSI was administered as late as 13 days after IRBP immunization. Our data demonstrate that Rbpj/Notch-mediated IL-22 production in T cells has a key pathological role in the late phase of EAU, and suggest that Notch blockade might be a useful therapeutic approach for treating EAU.
DOI: 10.1084/jem.189.2.219
发表时间: 1999-01-18
期刊: The Journal of experimental medicine
影响因子: --
作者:
Tarrant TK;Silver PB;Wahlsten JL;Rizzo LV;Chan CC;Wiggert B;Caspi RR
通讯作者: Caspi RR
DOI: 10.1385/ir:27:2-3:149
发表时间: 2003-01-01
影响因子: 4.4
作者:
Caspi, RR
通讯作者: Caspi, RR
DOI: 10.1016/s1074-7613(04)00109-8
发表时间: 2004-05-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Tanigaki, K;Tsuji, M;Honjo, T
通讯作者: Honjo, T
DOI: 10.4049/jimmunol.178.10.6567
发表时间: 2007-05-15
影响因子: 4.4
作者:
Kitamura, Mizuki;Iwabuchi, Kazuya;Onoe, Kazunori
通讯作者: Onoe, Kazunori
DOI: 10.4049/jimmunol.171.5.2652
发表时间: 2003-09-01
影响因子: 4.4
作者:
Sonoda, KH;Sasa, Y;Ishibashi, T
通讯作者: Ishibashi, T